Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading

Journal of Immune Based Therapies and Vaccines

Volumn 3, Issue , 2005, Pages

  Salskov Iversen, Maria ^a   Berger, Carole L ^b   Edelson, Richard L ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CANCER VACCINE; CD14 ANTIGEN; CD3 ANTIGEN; CD36 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYTOKINE; DENDRITIC CELL VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLOOD CELL; CANCER CELL; CANCER IMMUNOTHERAPY; CELL CLONING; CELL DIFFERENTIATION; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; CYTOKINE RELEASE; CYTOLYSIS; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKAPHERESIS; LEUKEMIA CELL; LEUKOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALIGNANT NEOPLASTIC DISEASE; MIXED LEUKOCYTE CULTURE; MONOCYTE; PHAGOCYTOSIS; PURIFICATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 27344449938     PISSN: 14768518     EISSN: 14768518     Source Type: Journal    
DOI: 10.1186/1476-8518-3-4     Document Type: Article

References (24)

1. Edelson RL: Cutaneous T cell lymphoma: Mycosis fungoides, Sézary syndrome and other variants. J Am Acad Dermatol 1980, 2:89-106.
2. Berger CL, Hanlon D, Kanada D, Dhodapkar M, Lombillo V, Wang N, Christensen I, Howe G, Crouch J, El-Fishawy P, Edelson R: The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Blood 2002, 99:2929-2939.
3. Berger C, Hanlon D, Kanada D, Girardi M, Edelson RL: Transimmunization, a novel approach for tumor immunotherapy. Transfus Apheresis Sci 2002, 3:205-216.
4. Girardi M, Schechner J, Glusac E, Berger C, Edelson R: Transimmunization and the evolution of extracorporeal photochemotherapy. Transfus Apheresis Sci 2002, 3:181-190.
5. Edelson RL, Berger CL, Gasparro FP, Jegasothy B. Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G, McKiernan G, Christiansen I, Oster M, Honigsmann H, Wilford H, Kokoschka E, Rehle T, Perez M, Stingl G, Laroche L: Treatment of leukemic cutaneous T cell lymphoma with extracorporeally photoactivated 8-Methoxypsoralen. N Engl J Med 1987, 316:297-303.
6. Berger CL, Xu A-L, Hanlon D, Lee C, Schechner J, Glusac E, Christensen I, Snyder E, Holloway V, Tigelaar R, Edelson RL: Large-scale induction of human tumor-loaded dendritic cells. Int J Cancer 2001, 91:4438-4447.
7. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA: Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998, 282:480-483.
8. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, Mirza A, Inaba K, Steinman RM, Mellman I: Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997, 388:787-792.
9. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y-H, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
10. Lannzavecchia A: Immunology: licence to kill. Nature 1998, 393:413-414.
11. Berger CL, Wang N, Christensen I, Longley J, Heald P, Edelson RL: The immune response to class I associated tumor-specific cutaneous T cell lymphoma antigens. J Invest Dermatol 1996, 107:392-397.
12. Berger C, Langley BJ, Imaeda S, Christensen I, Heald P, Edelson RL: Tumor-specific peptides in cutaneous T-cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor. Int J Cancer 1998, 76:304-311.
13. Winter D, Fiebiger E, Meraner P, Auer H, Brna C, Strohal R, Trautinger F, Knobler R, Fischer GF, Stingl G, Maurer D: Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma. J Immunol 2003, 171:2714-2724.
14. Ackerman AL, Kyritsis C, Tampé R, Cresswell P: Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nature Immunol 2004, 6:107-113.
15. Brossart P, Wirths S, Brugger W, Kanz L: Dendritic cells in cancer vaccines. Exp Hematol 2001, 29:1247-1255.
16. Reichardt VL, Brossart P, Kanz L: Dendritic cells in vaccination therapies of human malignant disease. Blood Rev 2004, 18:235-243.
17. Gong J, Koido S, Chen D, Tanaka Y, Huang L, Avigan D, Anderson K, Ohno T, Kufe D: Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12. Blood 2002, 99:2512-2517.
18. Jenne L, Schuler G, Steinkasserer A: Viral vectors for dendritic cell-based immunotherapy. Trends Immunol 2001, 22:102-107.
19. Nencioni A, Brossart P: Cellular immunotherapy with dendritic cells in cancer. Current status. Stem Cells 2004, 22:102-107.
20. Zic JA: The treatment of cutaneous T-cell lymphoma with photopheresis. Dermatologic Ther 2003, 16:337-346.
21. Steinman RM, Turley S, Mellman I, Inaba K: The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000, 191:411-416.
22. Delamarre L, Holcombe J, Mellman I: Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med 2003, 198:111-122.
23. Gallucci S, Lolkema M, Matzinger P: Natural adjuvants endogenous activators of dendritic cells. Nat Med 1999, 5:1249-1255.
24. Heald P, Rook A, Perez M, Wintroub B, Knobler R, Jegasothy B, Gasparro F, Berger C, Edelson R: Treatment of erythrodermic cutaneous T cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992, 27:427-433.